Scientists produce functional heart pacemaker cells

December 14, 2016, University Health Network
Dr. Stephanie Protze, post-doc fellow, and Dr. Gordon Keller, Director of the McEwen Centre for Regenerative Medicine, examine a cell cuture plate with human pacemaker cells generated from pluripotent stem cells for the first time. This development paves the way for a biological pacemaker taking the place of an electronic one. Credit: the McEwen Centre for Regenerative Medicine

Scientists from the McEwen Centre for Regenerative Medicine, University Health Network, have developed the first functional pacemaker cells from human stem cells, paving the way for alternate, biological pacemaker therapy.

Their findings, "Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker," published online in Nature Biotechnology on Dec. 12, detail how human can be coaxed in 21 days to develop into , which regulate heart beats with electrical impulses. These human pacemaker cells were tested in rat hearts and were shown to function as a biological pacemaker, by activating the electrical impulses that trigger the contraction of the heart.

Pluripotent stem cells have the potential to differentiate into more than 200 different cell types that make up every tissue and organ in the body.

Sinoatrial node pacemaker cells are the heart's primary pacemaker, controlling the heartbeat throughout life. Defects in the pacemaker can lead to heart rhythm disorders that are commonly treated by implantation of electronic pacemaker devices. Learning how to generate pacemaker cells could help in understanding disorders in pacemaker cells, and provide a cell source for developing a biological pacemaker. Biological pacemakers represent a promising alternative to electronic pacemakers, overcoming such drawbacks as a lack of hormonal responsiveness and the inability to adapt to changes in heart size in pediatric patients.

The researchers used a developmental-biology approach to establish a specific protocol for generating the pacemaker cells.

"What we are doing is human biology in a petri dish," says Dr. Gordon Keller, Director of the McEwen Centre, the senior author, and a trailblazer in generating a wide variety of specialized cells from human stem cells. "We are replicating nature's way of making the pacemaker cell."

This is an in-vitro (petri dish) demonstration of pacemaker heart cells generated from human stem cells from the McEwen Centre for Regenerative Medicine. Shown are a cluster of human pacemaker cells on top of a sheet of human heart muscle cells. The pacemaker cells initiate and regulate the heartbeat of the heart cells below. Credit: McEwen Centre for Regenerative Medicine

Based on previous findings in animal models, the researchers at the McEwen Centre tested and mapped out the specific developmental pathway of how human pluripotent stem cells become pacemaker cells. This was achieved by testing different signaling molecules at different times throughout the 21 days to guide the cells towards their goal.

"It's tricky," says Dr. Stephanie Protze, a post-doctoral fellow in the laboratory of Dr. Keller and the first author in the Nature paper. "You have to determine the right signaling molecules, at the right concentration, at the right time to stimulate the ."

Adds Dr. Keller, who is also a Professor in the Department of Medical Biophysics at the University of Toronto: "We understand the importance of precision in developmental biology in setting out the process by which organisms grow and develop. We use that same precision in the petri dish because we are replicating these same processes."

Once the team established which signaling pathways are activated at different stages to generate the pacemaker cells, they demonstrated that the new pacemaker cells could initiate and regulate the heartbeat in rats.

The researchers noted that human clinical trials to test such biological pacemakers are from five to 10 years away, and that the next step is to launch safety and reliability pre-clinical trials on the pacemaker cells.

Meanwhile, researchers can use their new technology to make pacemaker cells from patients suffering from pacemaker dysfunction. They can then use these patient-specific cells to study the "disease in a (petri) dish" and to identify new drugs that will improve their pacemaker function.

Long term, the team hopes to develop a biological pacemaker to transplant into patients who need an electronic one. More than 10,000 electric pacemakers are implanted annually in Canada, with more than 120,000 patients living with them. They can last anywhere from five to 10 years or more—on the average about seven years. If successful, the biological pacemaker holds the promise of a lifelong cure.

Explore further: Can stem cell technology be harnessed to generate biological pacemakers?

More information: Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker, Nature Biotechnology, nature.com/articles/doi:10.1038/nbt.3745

Related Stories

Can stem cell technology be harnessed to generate biological pacemakers?

November 20, 2015
Although today's pacemakers are lifesaving electronic devices, they are limited by their artificial nature. For example, their parts can fail or they can become infected. In addition, the devices require regular maintenance, ...

Ordinary heart cells become 'biological pacemakers' with injection of a single gene

December 16, 2012
Cedars-Sinai Heart Institute researchers have reprogrammed ordinary heart cells to become exact replicas of highly specialized pacemaker cells by injecting a single gene (Tbx18)–a major step forward in the decade-long search ...

Getting a pacemaker soon after heart valve replacement linked with worse outcomes

November 7, 2016
Patients who undergo minimally invasive heart valve replacement, known as TAVR, sometimes develop heart rhythm problems that necessitate placement of a permanent pacemaker. However, when a pacemaker is needed soon after TAVR, ...

'World's smallest pacemaker' appears promising in human trial

May 18, 2015
(HealthDay)—The world's smallest pacemaker is safe and effective in patients with symptomatic bradycardia, according to the first human clinical trial of the device. The findings were scheduled to be presented at the annual ...

Team discovers an unknown channel in the heart could illuminate unsolved cases of arrhythmia

June 11, 2013
The heart's regular rhythm is crucial to the delivery of oxygenated blood and nutrients to all the organs of the body. It is regulated by a bundle of cells called "the pacemaker," which use electrical signals to set the pace ...

FDA approves first pacemaker without wires from Medtronic

April 6, 2016
The Food and Drug Administration has approved the first pacemaker to do away with electrical wires that have long been a shortcoming of internal heart devices.

Recommended for you

Non-coding genetic variant could improve key vascular functions

November 15, 2018
Atherosclerotic disease, the slow and silent hardening and narrowing of the arteries, is a leading cause of mortality worldwide. It is responsible for more than 15 million deaths each year, including an estimated 610,000 ...

Study of two tribes sheds light on role of Western-influenced diet in blood pressure

November 14, 2018
A South American tribe living in near-total isolation with no Western dietary influences showed no increase in average blood pressure from age one to age 60, according to a study led by researchers at Johns Hopkins Bloomberg ...

Heart failure patients shouldn't stop meds even if condition improves: study

November 13, 2018
(HealthDay)—There's bad news for heart failure patients with dilated cardiomyopathy who'd like to stop taking their meds.

Bypass beats stents for diabetics with heart trouble: study

November 13, 2018
(HealthDay)—People with both diabetes and multiple clogged heart arteries live longer if they undergo bypass surgery rather than have their blood vessels reopened with stents, according to follow-up results from a landmark ...

Kawasaki disease: One disease, multiple triggers

November 12, 2018
Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography, and international collaborators have evidence that Kawasaki Disease (KD) does not have a single cause. By studying ...

New treatment significantly reduces cardiovascular events when combined with statins

November 12, 2018
Statins are the most commonly used treatment for cardiovascular disease. Despite reducing certain risk factors, if triglyceride levels remain high with use of statins, there is still a significant risk for heart attack, stroke ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.